Ascendis Pharma A/S (ASND)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

129.87

-0.29%

After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Revenue	266.72M	51.17M	7.78M	6.95M	13.38M	10.58M	1.53M	4.61M	8.12M	13.98M	20.41M	15.58M
Cost of Revenue	44.40M	12.14M	3.52M	-	-	-	-	-	-	-	-	-
Gross Profit	222.32M	39.04M	4.25M	6.95M	13.38M	10.58M	1.53M	4.61M	8.12M	13.98M	20.41M	15.58M
Operating Income	-455.54M	-561.81M	-451.79M	-330.62M	-226.72M	-154.76M	-111.54M	-72.92M	-41.83M	-11.99M	5.28M	1.51M
Interest Income	16.86M	52.18M	692.00K	1.81M	17.80M	4.02M	923.00K	123.00K	13.00K	-	-	-
Pretax Income	-474.14M	-577.82M	-383.94M	-419.17M	-218.25M	-130.49M	-124.37M	-68.73M	-33.57M	-10.34M	4.71M	1.28M
Net Income	-481.45M	-583.19M	-383.58M	-418.95M	-218.02M	-130.10M	-123.90M	-68.50M	-32.92M	-9.66M	4.08M	1.25M
Selling & General & Admin	264.41M	221.23M	160.18M	76.67M	48.47M	25.06M	13.48M	11.50M	9.41M	6.27M	2.42M	2.69M
Research & Development	413.45M	379.62M	295.87M	260.90M	191.62M	140.28M	99.59M	66.02M	40.53M	19.70M	12.71M	11.38M
Other Expenses	-	-	-	-	-	-	-	-	-0.00	-	-	-
Operating Expenses	677.86M	600.85M	456.05M	337.57M	240.09M	165.34M	113.07M	77.53M	49.94M	25.97M	15.13M	14.07M
Interest Expense	44.06M	50.49M	3.91M	1.92M	1.22M	127.00K	97.00K	5.00K	6.00K	16.00K	8.00K	20.00K
Selling & Marketing Expenses	-	-	-	-	-	-	-	-	-	-	-	-
Cost & Expenses	722.26M	612.99M	459.57M	337.57M	240.09M	165.34M	113.07M	77.53M	49.94M	25.97M	15.13M	14.07M
Income Tax	7.30M	5.38M	-367.00K	-219.00K	-234.00K	-394.00K	-477.00K	-227.00K	-652.00K	-682.00K	626.00K	35.00K
Shares Outstanding (Basic)	56.29M	56.07M	54.77M	50.62M	46.51M	41.09M	33.63M	26.56M	23.68M	16.94M	10.80M	10.80M
Shares Outstanding (Diluted)	56.29M	56.07M	54.77M	50.62M	46.51M	41.09M	33.63M	26.56M	23.77M	16.94M	10.80M	10.80M
EPS (Basic)	-8.55	-10.4	-7	-8.28	-4.69	-3.17	-3.68	-2.58	-1.39	-0.57	0.38	0.12
EPS (Diluted)	-8.55	-10.4	-7	-8.28	-4.69	-3.17	-3.68	-2.58	-1.39	-0.57	0.38	0.12
EBITDA	-411.17M	-556.04M	-423.67M	-328.88M	-217.03M	-150.18M	-109.88M	-72.12M	-33.01M	-11.48M	5.68M	1.73M
Depreciation & Amortization	18.91M	17.63M	16.00M	8.80M	6.67M	908.17K	689.46K	710.02K	558.00K	504.00K	405.00K	425.00K